MirambeauAppCare Will Attend 2018 CES in Las Vegas to Demo Their Diabilive Mobile App for Diabetes Patients

Media Contacts:
Kat Cavano – 703 531 8255
Jasmine Waterman – 703 533 4849
MirambeauAppCare Will Attend 2018 CES in Las Vegas to Demo Their Diabilive Mobile App for Diabetes Patients
Bordeaux France, December 15, 2017 – The French health-tech startup, MirambeauAppCare, will attend and showcase at the 2018 CES in Las Vegas. They will demonstrate their brand new mobile app, Diabilive, a 2018 CES Innovation Award Honoree.
MirambeauAppCare is a European company that develops medical applications for patients in accordance with their doctor’s prescriptions. Patients can create a network of collaborative ‘helpers’ and supervisors to oversee their care via the mobile app. This predictive medical system allows patients to anticipate their needs and researchers to analyze data to improve protocols.
MirambeauAppCare’s forthcoming mobile app, Diabilive which will be showcased at CES 2018, promises to be an all-in-one solution for Diabetes patients who self-administer insulin. With multi-user functionality, and safeguarding features, such as emergency SMS messages to caretakers, Diabilive allows for more autonomous insulin distribution for seniors and children. The application calculates the exact needed insulin dose based on medical protocol, diet and physical activity.
According to co-founder and CEO, Benoit Mirambeau, “The application facilitates full respect of the medical prescription and anticipates the needs of the patient. Thanks to better knowledge of his/her condition and the treatment needed, the protocol will be more precise. The patient will never be alone and will always be safe thanks to a network of caretakers.”
Diabilive is revolutionizing the in-home treatment of diabetes and innovating in the health-tech sphere by offering a comprehensive solution to an often difficult medical procedure. With immediate access to doctors or caretakers, and an intelligent algorithm giving real-time dosage information, diabetes patients now have access to a simpler and safer insulin process with Diabilive.
MirambeauAppCare was named a 2018 CES Innovation Awards Honoree for Diabilive and the team will be attending CES 2018 in Las Vegas on January 9-12 where they will demonstrate the revolutionary Diabilive app. They will be at booth 51244 at Sands Expo, Level 1, Hall G.
Note to Media:

To arrange for an interview and/or to receive more product information, please contact Kat Cavano at 703-531-8255 / kcavano@aboutbwf.com or Jasmine Watermine at 703-533-4849 / jwaterman@aboutbwf.com. For additional information on MirambeauAppCare, please visit http://www.diabilive.com